Stada Group
Ashok Narale is a seasoned professional in the pharmaceutical industry with extensive experience in quality assurance and auditing. Currently serving as the Jr. Manager Global Quality GMP Auditor at STADA Group since November 2023, Ashok previously held positions such as Senior Executive Corporate Quality Assurance at JB and FDC Pvt. Ltd. from August 2022 to November 2023 and September 2017 to August 2022, respectively. Ashok's earlier roles include Executive Corporate Quality Assurance at FDC PHARMA and Technology Transfer Officer at ACTAVIS PHARMA LIMITED (now Allergan). With an educational background that includes a Master of Business Administration in Production and Operation Management from Suresh Gyan Vihar University and a B.Pharmacy from Bharati Vidyapeeth College of Pharmacy, Ashok Narale possesses a strong foundation in both the operational and technical aspects of the pharmaceutical sector.
This person is not in any teams
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.